Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial-Reference-Cited by-同舟云学术

Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial

Published:2010-04 Issue:4 Volume:66 Page:385-392
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Hilden Jørgen,Lind Inga,Kolmos Hans Jørn,Als-Nielsen Bodil,Damgaard Morten,Hansen Jørgen Fischer,Hansen Stig,Helø Olav H.,Hildebrandt Per,Jensen Gorm Boje,Kastrup Jens,Kjøller Erik,Nielsen Henrik,Petersen Lars,Jespersen Christian M.,Gluud Christian

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference35 articles.

1. Infection, antibiotics and atherothrombosis—end of the road or new beginnings;Anderson;N. Engl. J. Med.,2005

2. Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection

3. Chlamydia pneumoniae, stroke, and serological associations. Anything learned from the atherosclerosis–cardiovascular literature or do we have to start over again?;Apfalter;Stroke,2006

4. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement;Arcari;CID,2005

5. Bennedsen M., (2003) Chlamydia pneumoniae. Assessment of the microimmunofluorescence test for antibody detection and prevalence studies in adult patients with respiratory tract infection. Thesis. University of Copenhagen, Copenhagen, Denmark.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotics for secondary prevention of coronary heart disease;Cochrane Database of Systematic Reviews;2021-02-23

2. Adverse events in people taking macrolide antibiotics versus placebo for any indication;Cochrane Database of Systematic Reviews;2019-01-18

3. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study;Atherosclerosis;2018-11

4. 10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy;Journal of the American Heart Association;2018-05

5. Atypical Pneumonia;Clinics in Chest Medicine;2017-03